Cluster-randomized controlled trial of intermittent preventive treatment in infancy using sulfadoxine-pyrimethamine (SP-IPTi): a pilot study in Nigeria.

Olumide Thomas AdelekeAbayomi OyenugaTina M SlusherDaniel A Gbadero

Published in: Journal of tropical pediatrics (2023)

Our study demonstrated that SP-IPTi had no benefit but was well tolerated. WHO and some researchers have also reported declining efficacy of SP, due to increasing drug resistance.

Keyphrases

study protocol
high intensity
clinical trial
physical activity
body mass index
replacement therapy
plasmodium falciparum
smoking cessation